ResearcherRutgers HealthNo recent work listed
Kien Pham
Matched on ORCID iD 0000-0002-3839-8777; OpenAlex author ID A5074733951. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2015: 2 papers · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 1 paper
Papers 7
- The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC. Last author DOI 10.1371/journal.pone.0226917↗
- PIK3CA in Kras G12D /Trp53 R172H Tumor Cells Promotes Immune Evasion by Limiting Infiltration of T Cells in a Model of Pancreatic Cancer Co-author DOI 10.1101/521831↗
- Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer. Co-author DOI 10.1172/jci123540↗
- Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment. Co-author DOI 10.1158/0008-5472.can-16-1765↗
- Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserved Heterogeneity in Culture. Co-author DOI 10.1016/j.ajpath.2016.02.009↗
- Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in hum… Co-author DOI 10.1007/s00262-015-1760-y↗
- Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorporation of murine stromal elements. First author DOI 10.1016/j.ajpath.2015.01.016↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chen Liu · 7 shared papers, 2015–2020 · strength 0.49
- Paper The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therap… DOI 10.1371/journal.pone.0226917↗
- Paper PIK3CA in Kras G12D /Trp53 R172H Tumor Cells Promotes Immune Evasion by Limiting Infiltration of T Cells in a Model of … DOI 10.1101/521831↗
- Paper Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer. DOI 10.1172/jci123540↗
- Daniel Delitto · 5 shared papers, 2015–2020 · strength 0.30
- Paper The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therap… DOI 10.1371/journal.pone.0226917↗
- Paper Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenviron… DOI 10.1158/0008-5472.can-16-1765↗
- Paper Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserve… DOI 10.1016/j.ajpath.2016.02.009↗
- Ryan Michael Thomas · 4 shared papers, 2015–2017 · strength 0.20
- Paper Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenviron… DOI 10.1158/0008-5472.can-16-1765↗
- Paper Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserve… DOI 10.1016/j.ajpath.2016.02.009↗
- Paper Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorp… DOI 10.1016/j.ajpath.2015.01.016↗
- K.E. Behrns · 4 shared papers, 2015–2017 · strength 0.20
- Paper Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenviron… DOI 10.1158/0008-5472.can-16-1765↗
- Paper Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserve… DOI 10.1016/j.ajpath.2016.02.009↗
- Paper Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorp… DOI 10.1016/j.ajpath.2015.01.016↗
- Shannon Margaret Wallet · 4 shared papers, 2015–2017 · strength 0.20
- Paper Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenviron… DOI 10.1158/0008-5472.can-16-1765↗
- Paper Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserve… DOI 10.1016/j.ajpath.2016.02.009↗
- Paper Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorp… DOI 10.1016/j.ajpath.2015.01.016↗
- Steven J. Hughes · 4 shared papers, 2015–2017 · strength 0.20
- Paper Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenviron… DOI 10.1158/0008-5472.can-16-1765↗
- Paper Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserve… DOI 10.1016/j.ajpath.2016.02.009↗
- Paper Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorp… DOI 10.1016/j.ajpath.2015.01.016↗
- Jose Gilberto Trevino · 4 shared papers, 2015–2017 · strength 0.20
- Paper Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenviron… DOI 10.1158/0008-5472.can-16-1765↗
- Paper Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserve… DOI 10.1016/j.ajpath.2016.02.009↗
- Paper Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorp… DOI 10.1016/j.ajpath.2015.01.016↗
- Nithya Sivaram · 2 shared papers, 2019 · strength 0.19
- Han V. Han · 2 shared papers, 2019 · strength 0.19
- Richard Z Lin · 2 shared papers, 2019 · strength 0.19
- Thomas J. George · 3 shared papers, 2015–2017 · strength 0.15
- Paper Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenviron… DOI 10.1158/0008-5472.can-16-1765↗
- Paper Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserve… DOI 10.1016/j.ajpath.2016.02.009↗
- Paper Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance… DOI 10.1007/s00262-015-1760-y↗
- Matthew Brown · 1 shared paper, 2020 · strength 0.11
- Song Han · 2 shared papers, 2015–2017 · strength 0.10
- Paper Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenviron… DOI 10.1158/0008-5472.can-16-1765↗
- Paper Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance… DOI 10.1007/s00262-015-1760-y↗
- Michael H. Gerber · 1 shared paper, 2017 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.